What is the maximum percentage of C2-C5 drugs that an RPH is allowed to compound in a dosage form?

The correct response indicates that an RPH (Registered Pharmacist) in Connecticut is allowed to compound a maximum of 20% of dosage forms containing substances classified as Schedule II through Schedule V (C2-C5) drugs. This percentage reflects regulatory guidelines that aim to ensure appropriate use of controlled substances in compounded medications, balancing the need for patient care with the control measures designed to prevent misuse and abuse of these drugs.

In compounding scenarios, the rationale for limiting the percentage of controlled substances is to promote safety and efficacy in compounded preparations while adhering to the standards set forth by both state and federal regulations. These regulations are in place to minimize the potential for diversion of these potent medications and ensure that compounded products serve their intended therapeutic purposes without compromising patient safety or care.

The options that exceed this percentage reflect a misunderstanding of the regulations surrounding compounding controlled substances, as they do not align with the established guidelines for community and clinical pharmacy practice regarding controlled substances. Such limitations safeguard public health by ensuring compounded medications are subject to appropriate oversight and monitoring.